English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 18240/20438 (89%)
造訪人次 : 5456153      線上人數 : 1416
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    請使用永久網址來引用或連結此文件: https://ir.cnu.edu.tw/handle/310902800/34923


    標題: Thiamet G as a Potential Treatment for Polycystic Kidney Disease
    作者: Su, Wen-Cheng
    Hung, Chi-Feng
    Wang, Yi-Chieh
    Peng, Hubert
    Huang, Wen-Hung
    Lo, Yi-Lun
    Lo, Yun-Hwa
    Chen, Yi-Cheng
    Su, Hsin-Hui
    Chen, Yung-Liang
    貢獻者: Yuan Pei Univ Med Technol, Dept Med Lab Sci & Biotechnol
    Chia yi Christian Hosp, Ditmanson Med Fdn, Dept Urol
    Natl Cheng Kung Univ, Coll Med, Dept Biochem & Mol Biol
    Acad Sinica, Inst Mol Biol
    Natl Yang Ming Chiao Tung Univ, Coll Med, Inst Pharmacol
    Kaohsiung Med Univ, Coll Life Sci, Dept Med & Appl Chem
    Natl Pingtung Univ Sci & Technol, Dept Vet Med
    Chia Nan Univ Pharm & Sci, Dept Pharm
    Yuan Pei Univ Sci & Technol, Dept Med Lab Sci & Biotechnol
    Chia Nan Univ Pharm & Sci, Dept Pharm
    關鍵字: Autosomal dominant polycystic kidney disease
    ADPKD
    O-linked N-acetylglucosamine
    Thiamet G
    日期: 2023
    上傳時間: 2024-12-25 11:05:42 (UTC+8)
    出版者: INT INST ANTICANCER RESEARCH
    摘要: Background/Aim: Autosomal dominant polycystic kidney disease (ADPKD) is a prevalent genetic disorder primarily caused by mutations in Pkd1 (PC1), which account for the majority of ADPKD cases. These mutations contribute to the formation of cysts in the kidneys and other organs, ultimately leading to renal failure. Unfortunately, there are currently no available preventive treatments for this disease. Materials and Methods: In this study, we utilized Pkd1-knockdown mice and cells to investigate the potential involvement of O-GlcNAcylation in the progression of PKD. Additionally, we examined the effects of thiamet G, an inhibitor of O-GlcNAcase (OGA), on PKD mice. Results: Our findings indicate that both O-GlcNAcylation and OGT (O-GlcNAc transferase) were downregulated in the renal tissues of Pkd1-silenced mice. Furthermore, OGlcNAcylation was shown to regulate the stability and function of the C-terminal cytoplasmic tail (CTT) of PC1. Treatment of PKD mice with thiamet G resulted in a reduction of renal cytogenesis in these animals. Conclusion: These results highlight the unique role of O-GlcNAcylation in the development of cyst formation in PKD and propose it as a potential therapeutic target for the treatment of PKD.
    關聯: In Vivo, v.37, n.6, pp.2524-2532
    顯示於類別:[行政單位] 456

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    index.html0KbHTML1檢視/開啟


    在CNU IR中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋